A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of L-000796568 in Postmenopausal Women With Overactive Bladder

Update Il y a 4 ans
Reference: EUCTR2005-004499-19

Woman Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

In postmenopausal women with overactive bladder: (1) To investigate a dose-related reduction, in average number of daily micturitions after 8 weeks of treatment with L 000796568 (375, 125, or 50 mg once daily), compared with placebo. (2) To evaluate the safety and tolerability of daily treatment with L-000796568 (375, 125, or 50 mg/d).


Inclusion criteria

  • Overative Bladder